Tag Archives: Dementia Prevention

Blood Pressure in Early Middle Age Linked to Vascular Dementia Risk (BBC News / Lancet Neurology)

Posted on August 22, 2019 by Dementia and Elderly Care News

Summary Epidemiological research indicates that high blood pressure in early mid-life (i.e. people in their 30s and 40s) is associated with blood vessel damage, brain shrinkage and vascular dementia risk in later life. Full Text Link Reference High blood pressure … Continue reading →

Healthy Lifestyles May Partially Help Offset Genetic Risk Factors for Dementia (BBC News / JAMA / Bazian)

Posted on July 17, 2019 by Dementia and Elderly Care News

Summary Persons in the UK Biobank study were followed over time to discover whether pursuing a healthy lifestyle (not smoking, regular physical activity, healthy diet and moderate alcohol consumption) might be associated with lower risk of developing dementia regardless of predisposing genetic risk factors. Statistically, favourable (“healthy”) lifestyles … Continue reading →

Posted in BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged Active Lifestyle, Ageing Population, Alan Turing Institute, Albertinen-Haus Centre for Geriatrics and Gerontology: University of Hamburg, Alzheimer’s Association International Conference (AAIC®2019), Association Between Physical Activity and Cognitive Function and / or Dementia, Association of Lifestyle and Genetic Risk Factors With Incidence of Dementia, Australia, Australian Centre for Precision Health: University of South Australia, Bazian, BBC Health News, Behind the Headlines, Cigarette Smoking, Clinical Trial Service Unit and Epidemiological Studies Unit: University of Oxford, Cognitive Impairment (Potential Risk and Protective Factors), Cognitive Impairment (Potential Risk Factors), Critical Appraisals, Cumulative Benefit of Reducing Risk Factors, Dementia and Geriatric Cognitive Disorders, Dementia Prevention, Dementia Risk Factors, Dementia Risk Reduction and Prevention, Department of Health Economics and Health Services Research: Hamburg Center for Health Economics, Division of General Medicine: University of Michigan, Epidemiology, Epidemiology and Statistics, Genetic Risk Factors, Genetic Risk Factors for Alzheimer’s Disease, Germany, Great Ormond Street Institute of Child Health, Hamburg Center for Health Economics, Healthy Behaviours, Healthy Diet, Healthy Lifestyle Score: Based on Four Established Dementia Risk Factors (Smoking Physical Activity Diet and Alcohol Consumption), Healthy Lifestyles, Healthy Living, Institute for Healthcare Policy and Innovation: University of Michigan, Institute for Social Research: University of Michigan, JAMA, Journal of the American Medical Association (JAMA), Later Life, Life-Course Approach to Healthy and Active Ageing, Lifestyle Factors, Lifestyle Risk Factors, Mild Cognitive Impairment (MCI), Moderate Alcohol Consumption, Moderate Exercise, Modifiable Risk Factors, Neurological Disorders, Neuroprotective Lifestyles, NIHR CLAHRC South West Peninsula (PenCLAHRC), Nuffield Department of Population Health: University of Oxford, Nutritional and Metabolic Disorders, Obesity Risk Factor, Overlapping Risk Factors, Physical Activity and Health Benefits, Physical Activity Before Dementia, Physical Exercise, Physical Exercise Programmes, Physical Inactivity, Polygenic Risk Score: Individual’s Load of Common Genetic Variants Associated with Alzheimer's Disease and Dementia Risk, Population Policy and Practice: University College London, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Prevention, Prevention Agenda, Prevention Better Than Cure, Prevention of Dementia, Preventive Care, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Reducing the Incidence of Dementia, Regular Physical Activity, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, Scientific Department: University of Hamburg, Smoking, Smoking Cessation, Social Epidemiology, South Australia, Staying Healthy for Longer, Tobacco Consumption, UK Biobank, Unhealthy Lifestyles, United States, University College London, University of Exeter, University of Exeter Medical School, University of Hamburg, University of Michigan, University of Oxford, University of South Australia, University of South Australia Cancer Research Institute, USA, Veterans Affairs Center for Clinical Management Research in Michigan, Veterans Affairs Center for Clinical Management Research: Michigan | Leave a comment

WHO Guidelines on Dementia Prevention (BBC News / WHO)

Posted on May 15, 2019 by Dementia and Elderly Care News

Summary The World Health Organization (WHO) has issued guidelines on the prevention of cognitive decline and dementia. This follows earlier related guidance and consensus statements from other bodies, nationally and internationally, which recommend the adoption of healthy lifestyles for healthier … Continue reading →

Posted in Commissioning, Community Care, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Models of Dementia Care, Non-Pharmacological Treatments, Quick Insights, Standards, Universal Interest, World Health Organization (WHO) | Tagged Active and Healthy Ageing, Ageing and Dementia, Ageing Population, Alcohol and Drug Consumption, Alcohol Consumption, Alcohol Misuse, Alcohol or Tobacco Withdrawal, Alcohol Use Disorders (AUDs), Alcohol Use Disorders and Cognitive Impairment Risk, BBC Health News, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Blood Pressure, Cardiovascular Risk Factors (CVRF), Cholesterol (Dyslipidaemia), Cognitive Decline and Dementia: Risk Reduction, Cumulative Benefit of Reducing Risk Factors, Dementia and Sensory Loss, Dementia Policy, Dementia Prevention, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Diabetes Mellitus, Diet and Dementia, Dietary Factors, Eating and Drinking, Education and Awareness, Global Action Plan for Public Health Response to Dementia (WHO), Healthy Ageing, Healthy Lifestyles, Healthy Lifestyles and Public Health Programmes, Healthy Living, Hearing Loss, Hearing Loss and Cognitive Decline, Hearing Loss and Dementia, Hypertension, Later Life, Life-Course Approach to Healthy and Active Ageing, Lifestyle Risk Factors, Lifestyle Weight Management, Midlife Hypertension, Modifiable Risk Factors, Mortality Risk Factors, Neurological Disorders, Obesity, Obesity Risk, Obesity Time-Bomb, Participation in Social Activities, Physical Activity, Preventing Type 2 Diabetes, Prevention, Prevention Agenda, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention Approaches, Prevention Better Than Cure, Prevention of Dementia, Prevention Programmes, Preventive Care, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Public Awareness, Public Health, Public Health Interventions, Reducing the Incidence of Dementia, Risk Factors, Risk Factors and Preventive Interventions for Cognitive Impairment, Risk Factors and Preventive Interventions for Dementia, Risk Reduction of Cognitive Decline and Dementia, Sensory Loss, Smoked Tobacco, Social Activities, Staying Healthy for Longer, Successful Ageing, Supporting Healthy Lifestyles, Tobacco Cessation, Type 2 Diabetes, Type 2 Diabetes: Prevention, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, Weight Management, Weight Management Programs, WHO Global Dementia Observatory (GDO), WHO Guidelines, WHO Guidelines on Dementia Prevention, WHO’s Global Dementia Observatory, World Health Organization (Geneva), World Health Organization (WHO) Guidelines on Dementia Prevention | Leave a comment

The State of Dementia Research Globally: World Alzheimer Report 2018 (Alzheimer’s Disease International)

Posted on March 2, 2019 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2018, entitled “The state of the art of dementia research: New frontiers”, reviews developments in dementia research, without glossing-over the absence of significant disease-modifying pharmacological treatment breakthroughs for around 20 years. This report examines wide-ranging … Continue reading →

Posted in Acute Hospitals, Alzheimer’s Disease International (ADI), Charitable Bodies, Community Care, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Alireza Atri: Director of Banner Sun Health Research Institute, Alzheimer's Research, Alzheimer’s Disease International (ADI), Alzheimer’s Disease Research Unit: McGill Centre for Studies in Ageing (Canada), Alzheimer’s Prevention Initiative: Banner Health (USA), Alzheimer’s Prevention Initiative: Banner Sun Health Research Institute, Banner Sun Health Research Institute, Burden of Alzheimer’s Disease, Burden of Dementia (Statistics), Centre for Dementia Prevention: University of Edinburgh, Dementia as Cause of Death, Dementia Awareness, Dementia Awareness Raising, Dementia Collaborative Research Centre: University of New South Wales, Dementia Discovery Fund, Dementia Discovery Fund (DDF), Dementia Prevention, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Risk Reduction, Dementia Risk Reduction and Prevention, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Disease-Modifying Treatments for Dementia, Dr Christopher Chen: Director of Memory Ageing and Cognition Centre at National University Health System: Singapore, Dr Doug Brown: Chief Executive Officer of British Society for Immunology, Dr Doug Brown: Former Chief Policy and Research Officer at Alzheimer’s Society, Dr Jennifer Bute: Dementia Alliance International (DAI), Dr Kenji Toba: President of National Centre for Geriatrics and Gerontology (Obu), Dr Maria Carrillo: Chief Science Officer at Alzheimer’s Association US, Dr Miia Kivipelto: Karolinska Institute, Dr Miia Kivipelto: Karolinska University Hospital (Stockholm), Dr Rachelle Doody: Global Head of Neurodegeneration at Roche, Dr Serge Gauthier: Director of Alzheimer’s Disease Research Unit at McGill Centre for Studies in Ageing in Canada, Drug Trials Failure Rate, Epidemiology, Epidemiology and Statistics, Francesca Colombo: Organisation for Economic Co-operation and Development (OECD), Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Glenn Rees: Chairman of Alzheimer’s Disease International, Glenn Rees: Former CEO of Alzheimer’s Australia, Global Burden of Dementia, Global Dementia Discovery Fund (2015), Identification and Intervention for Dementia in Elderly Africans (IDEA Group), Jeff Cummings: Director of Cleveland Clinic at Lou Ruvo Centre for Brain Health, Kate Bingham: SV Health Managers, King’s College London, Market Failure (Dementia Research and Drug Development), Martin Knapp: London School of Economics, Memory Ageing and Cognition Centre at National University Health System: Singapore, Memory Ageing and Cognition Centre: National University Health System (Singapore), National Centre for Geriatrics and Gerontology (Japan), Optima (University of Oxford’s Dementia Research Project), OPTIMA Cohort (Oxford Project to Investigate Memory and Ageing), Oxford Project to Investigate Memory and Ageing (OPTIMA Study), Paola Barbarino: Alzheimer’s Disease International, Prevention, Prevention Agenda, Prevention of Future Dementia Cases by Increasing Knowledge of Risk and Protective Factors, Professor Adesola Ogunniyi: University College Hospital (Ibadan), Professor Bart De Strooper: Director of the UK Dementia Research Institute (UK DRI), Professor Craig Ritchie: Chair of Psychiatry of Ageing at University of Edinburgh, Professor Craig Ritchie: Director at Centre for Dementia Prevention, Professor Gordon Wilcock: Co-founder of Alzheimer’s Society UK, Professor Gordon Wilcock: Emeritus Professor of Geratology at University of Oxford, Professor Henry Brodaty: Director of Dementia Collaborative Research Centre at University of New South Wales, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Prince: Assistant Principal for Global Health at King’s College London, Research Networks, Ricardo Allegri: Head of Cognitive Neurology Neuropsychology and Neuropsychiatry at Fundación para la Lucha contra las Enfermedades Neurológicas (FLENI), Risk and Protective Factors, State of the Art of Dementia Research: New Frontiers (World Alzheimer Report 2018), Supporting People Affected by Dementia, UK Dementia Research Institute, UK Dementia Research Institute (UK DRI), UK Dementia Research Institute at UCL, University College Hospital (Ibadan Nigeria), World Alzheimer Report, World Alzheimer Report 2018: State of the Art of Dementia Research, World Alzheimer Report: 2018, World Alzheimer’s Day 2018 | Leave a comment

Global Burden of Disease (Alzheimer’s Disease and Other Dementias, 1990-2016) Study: 2018 Update (Lancet Neurology)

Posted on December 15, 2018 by Dementia and Elderly Care News

Summary An update to the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study of 2016 has been published. The number of people living with dementia globally appears to have more than doubled between 1990 to 2016. “In the … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Quick Insights, Statistics, Systematic Reviews, Universal Interest | Tagged Age Standardised Death Rates, Age-Standardised Years of Life Lost (SYLL), Ageing Population, All-Cause Mortality, All-Cause Mortality and Cause-Specific Mortality for 249 Causes of Death (1980–2015), Alzheimer’s Disease: Prevalence, Amenable Mortality, Behavioural Risk Factors, Bill and Melinda Gates Foundation, DALYs, Dementia and Mortality, Dementia Prevention, Dementia Risk Factors, Diet High in Sugar-Sweetened Beverages, Disability Adjusted Life Years (DALY), Disease Burden, DisMod-MR 2.1 Model, Epidemiology, Epidemiology and Statistics, GBD 2016 Alzheimer’s Disease and Other Dementia Collaborators, Global Burden of Diseases Injuries and Risk Factors (GBD) Study, High Body-Mass Index (BMI), High Fasting Plasma Glucose, Lancet Neurology, Life Expectancy, Lifestyle Risk Factors, Modeling Causes of Death: Integrated Approach Using CODEm, Modifiable Risk Factors, Mortality, Prevalence, Prevalence of Cancer, Prevalence of Dementia, Prevention, Prevention Agenda, Prevention Programmes, Public Health, Risk Factors, Smoking, Social Epidemiology, Sugar- and Artificially Sweetened Beverages, Years Lost Due to Disability (YLD), Years of Life Lost (YLLs), YLDs | Leave a comment

Risk of Dementia in Patients Using Antidepressants? (Behavioural Neurology / BBC News)

Posted on October 23, 2018 by Dementia and Elderly Care News

Summary Evidence indicating that use of antidepressants is associated significantly with an increased risk of developing dementia: Full Text Link Reference Wang, YC. Tai, PA. [and] Poly, TN. [et al] (2018). Increased risk of dementia in patients with antidepressants: a … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Quick Insights, Systematic Reviews, Universal Interest | Tagged Anti-Depressant Drugs, Antidepressant Prescriptions in England, Antidepressants, Antidepressants and Risk of Dementia, BBC Health News, Behavioural Neurology (Journal), Buddhist Tzu Chi University (Hualien Taiwan), Cognitive Impairment (Potential Risk and Protective Factors), Cognitive Impairment (Potential Risk Factors), College of Medical Science and Technology: Taipei Medical University, Dementia Prevention, Dementia Risk Factors, Dementia Risk Reduction and Prevention, Department of Dermatology: Wan Fang Hospital, Department of Emergency: Min-Sheng General Hospital, Department of Surgery: Buddhist Tzu Chi University, Epidemiology, Epidemiology and Statistics, Graduate Institute of Biomedical Informatics: Taipei Medical University, Min-Sheng General Hospital (Taoyuan City Taiwan), Modifiable Risk Factors, Mono-Amine Oxidase Inhibitors (MAOIs), Monoamine-Oxidase B Inhibitors, Neurocognitive Disorders, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Overlapping Risk Factors, Prevention, Prevention Agenda, Prevention of Dementia, Primary and Secondary Prevention of Dementia, Risk Factors, School of Medicine: Buddhist Tzu Chi University, Selective Serotonin Reuptake Inhibitors (SSRIs), SSRIs: Selective Serotonin Reuptake Inhibitors, Systematic Reviews and Meta-Analyses, Taipei Medical University, Taiwan, TMU Research Center of Cancer Translational Medicine (Taipei Taiwan), Tricyclic Antidepressants, Tricyclics (TCAs), Wan Fang Hospital (Taipei Taiwan) | Leave a comment

Summary of Recent Progress in Alzheimer’s Disease Prevention Trials (CTAD / JPAD)

Posted on October 1, 2018 by Dementia and Elderly Care News

Summary The following article summarises a round-up of present understanding and developments reflected in current and planned prevention trials, as discussed at a EU / US / Clinical Trials in Alzheimer’s Disease (CTAD) Task Force meeting, as of December 2016-7. … Continue reading →

Tag Archives: Dementia Prevention

Blood Pressure in Early Middle Age Linked to Vascular Dementia Risk (BBC News / Lancet Neurology)

Risk of Dementia in Patients Using Antidepressants? (Behavioural Neurology / BBC News)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites